Trafalgar International (GCAN) Common Equity (2016 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Common Equity of -$775025.0 for Q1 2026, up 5.94% year-over-year from -$731557.7 in Q1 2025, and down 4.5% quarter-over-quarter from -$741649.0 in Q4 2025.
Trafalgar International (GCAN) Common Equity (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Common Equity history runs 11 years deep, the most recent figure standing at -$775025.0 for Q1 2026.
- In Q1 2026, Common Equity rose 5.94% year-over-year to -$775025.0; the TTM figure through Mar 2026 stood at -$775025.0 (up 5.94% YoY), while the FY2025 annual figure was -$741649.0, up 11.74% from the prior year.
- Common Equity for Q1 2026 stood at -$775025.0, down from -$741649.0 in the prior quarter.
- The five-year high for Common Equity was -$544830.0 in Q4 2022, with the low at -$1.1 million in Q3 2025.
- The 5-year median for Common Equity is -$705843.0 (2024), against an average of -$736008.6.
- The sharpest annual moves came in 2022 and 2025: Common Equity plunged 642.21% in 2022, then climbed 11.74% in 2025.
- Greater Cannabis Company's Common Equity stood at -$544830.0 in 2022, then fell by 21.36% to -$661232.0 in 2023, then dropped by 27.08% to -$840273.0 in 2024, then increased by 11.74% to -$741649.0 in 2025, then fell by 4.5% to -$775025.0 in 2026.
- Business Quant data shows GCAN's Common Equity at -$775025.0 in Q1 2026, -$741649.0 in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 4.05 Bn |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | -775,025.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -775,025.00 |
| Dec 31, 2025 | -741,649.00 |
| Sep 30, 2025 | -1.11 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Mar 31, 2025 | -823,984.00 |
| Dec 31, 2024 | -840,273.00 |
| Sep 30, 2024 | -796,925.00 |
| Jun 30, 2024 | -750,760.00 |
| Mar 31, 2024 | -705,843.00 |
| Dec 31, 2023 | -661,232.00 |
| Sep 30, 2023 | -650,371.00 |
| Jun 30, 2023 | -632,941.00 |
| Mar 31, 2023 | -587,898.00 |
| Dec 31, 2022 | -544,830.00 |
| Sep 30, 2022 | -561,429.00 |
| Jun 30, 2022 | -641,653.00 |
| Mar 31, 2022 | -616,748.00 |
| Dec 31, 2021 | -469,062.00 |
| Sep 30, 2021 | -272,731.00 |
| Jun 30, 2021 | -86,452.00 |